686298-00-0 Usage
Uses
Used in Scientific Research and Drug Development:
4-(Benzylpiperazine-4-yl)piperidine dihydrochloride is used as a research chemical for studying its psychoactive properties and potential effects on the central nervous system. Its role in this context is to aid in the development of new drugs and therapies that may target neurological disorders or conditions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(Benzylpiperazine-4-yl)piperidine dihydrochloride is utilized as a starting material or intermediate in the synthesis of various drugs. Its unique structure and potential interactions with biological targets make it a valuable component in the creation of novel medications.
Used in Neuropharmacology:
4-(Benzylpiperazine-4-yl)piperidine dihydrochloride is employed as a neuropharmacological tool to investigate the mechanisms of action and potential therapeutic applications related to the central nervous system. Its effects on neurotransmission and receptor binding provide insights into the development of treatments for neurological and psychiatric conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 686298-00-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,6,2,9 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 686298-00:
(8*6)+(7*8)+(6*6)+(5*2)+(4*9)+(3*8)+(2*0)+(1*0)=210
210 % 10 = 0
So 686298-00-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H25N3.2ClH/c1-2-4-15(5-3-1)14-18-10-12-19(13-11-18)16-6-8-17-9-7-16;;/h1-5,16-17H,6-14H2;2*1H
686298-00-0Relevant academic research and scientific papers
SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT
-
Page/Page column 100-101, (2008/06/13)
The invention relates to CGRP antagonists of general formula (I), in which A, U, V, W, X and R1 to R 3 are as defined in claim 1, the tautomers, diastereomers, enantiomers, hydrates, mixtures, salts, hydrates of the salts, in particular the physiologically-acceptable salts thereof with inorganic or organic acids, medicaments containing said compounds and the use and methods for production thereof.
